PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Harvard Pilgrim Health CareMedicaid · Prior Auth · Prior Authorization · Dermatology, Genetics, Pediatrics +2 moreMedium impact

Point32Health medical drug program updates

Act
by Nov 17, 2025
Effective date
Nov 17, 2025
Identified
Jun 20, 2026

Summary

Point32Health (Harvard Pilgrim and Tufts Health Plan) is implementing new prior authorization requirements for four newly FDA-approved drugs: Zevaskyn, Enflonsia, Qfitlia, and Yeztugo, effective November 17, 2025. Additionally, prior authorization criteria for Vyjuvek are being updated to clarify usage restrictions and prescriber requirements.

Get alerts when payers change rules like this one

We check Harvard Pilgrim Health Care and other payers every day and email you when a change matches your specialty and state.

Get Harvard Pilgrim Health Care alertsPolicy Monitoring is free. No card required.

What to do

by Nov 17, 2025 · 3 steps
01Billing team must update prior authorization workflows for new drugs Zevaskyn (J3590), Enflonsia (RSV prevention), Qfitlia (hemophilia), and Yeztugo (HIV PrEP) for Tufts Health Together members.
02Refer to MassHealth Drug List for coverage criteria.
03For Vyjuvek, ensure prescriber is documented as a specialist or specialist consult notes are provided before submitting claims.

Codes mentioned

J3590

Original notice

Point32Health medical drug program updates
point32health.org · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account